REFERENCES:
1. Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;18:20.
2. Bach F, Albertini R, Joo P, Anderson J, Bortin M. BONE-MARROW TRANSPLANTATION IN A PATIENT WITH THE WISKOTT-ALDRICH SYNDROME. Lancet [Internet]. 1968 Dec [cited 2015 Jun 30];292(7583):1364–6. Available from: http://www.sciencedirect.com/science/article/pii/S014067366892672X
3. European Society for Blood and Marrow Transplantation, European Society for Immunodeficiencies. EBMT / ESID Guidelines for Haematopoietic Stem Cell Transplantation for Primary Immunodeficiencies. ESID EBMT HSCT Guidel 2017 [Internet]. 2017; Available from: https://www.ebmt.org/ebmt/documents/esid-ebmt-hsct-guidelines-2017%0Ahttps://esid.org/layout/set/print/Working-Parties/Inborn-Errors-Working-Party-IEWP/Resources/UPDATED!-EBMT-ESID-GUIDELINES-FOR-HAEMATOPOIETIC-STEM-CELL-TRANSPLANTATION-FOR-PI
4. Amayiri N, Al-Zaben A, Ghatasheh L, Frangoul H, Hussein AA. Hematopoietic stem cell transplantation for children with primary immunodeficiency diseases: Single center experience in Jordan. Vol. 17, Pediatric Transplantation. 2013. p. 394–402.
5. Pai SY, Cowan MJ. Stem cell transplantation for primary immunodeficiency diseases: The North American experience. Curr Opin Allergy Clin Immunol. 2014;14(6):521–6.
6. Cavazzana M, Touzot F, Moshous D, Neven B, Blanche S, Fischer A. Stem cell transplantation for primary immunodeficiencies: The European experience. Curr Opin Allergy Clin Immunol. 2014;14(6):516–20.
7. Moratto D, Giliani S, Bonfim C, Mazzolari E, Fischer A, Ochs HD, et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study. Blood [Internet]. 2011 Aug 11 [cited 2014 Jul 10];118(6):1675–84. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3156052&tool=pmcentrez&rendertype=abstract
8. Patiroglu T, Akar HH, Unal E, Ozdemir MA, Karakukcu M. Hematopoietic stem cell transplant for primary immunodeficiency diseases: A single-center experience. Exp Clin Transplant. 2017 Jun 1;15(3):337–43.
9. Yi ES, Choi YB, Lee NH, Lee JW, Sung KW, Koo HH, et al. Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center. J Clin Immunol. 2018;38(7):767.
10. Uppuluri R, Sivasankaran M, Patel S, Swaminathan VV, Ramanan KM, Ravichandran N, et al. Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immune Deficiency Disorders in Children: Challenges and Outcome from a Tertiary Care Center in South India. J Clin Immunol. 2019 Feb 1;39(2):182–7.
11. Neven B, Diana JS, Castelle M, Magnani A, Rosain J, Touzot F, et al. Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children. Biol Blood Marrow Transplant. 2019;25(7):1363–73.
12. Slater M. OLYMPICS Olympics cycling : Marginal gains underpin Team GB dominance [Internet]. BBC Sport. 2012 [cited 2019 Dec 17]. p. 1–2. Available from: https://www.bbc.com/sport/olympics/19174302